Distinctive genotypes in infants with T‐cell acute lymphoblastic leukaemia

Infant T‐cell acute lymphoblastic leukaemia (iT‐ALL) is a very rare and poorly defined entity with a poor prognosis. We assembled a unique series of 13 infants with T‐ALL, which allowed us to identify genotypic abnormalities and to investigate prenatal origins. Matched samples (diagnosis/remission) were analysed by single nucleotide polymorphism‐array to identify genomic losses and gains. In three cases, we identified a recurrent somatic deletion on chromosome 3. These losses result in the complete deletion of MLF1 and have not previously been described in T‐ALL. We observed two cases with an 11p13 deletion (LMO2‐related), one of which also harboured a deletion of RB1. Another case presented a large 11q14·1‐11q23·2 deletion that included ATM and only five patients (38%) showed deletions of CDKN2A/B. Four cases showed NOTCH1 mutations; in one case FBXW7 was the sole mutation and three cases showed alterations in PTEN. KMT2A rearrangements (KMT2A‐r) were detected in three out of 13 cases. For three patients, mutations and copy number alterations (including deletion of PTEN) could be backtracked to birth using neonatal blood spot DNA, demonstrating an in utero origin. Overall, our data indicates that iT‐ALL has a diverse but distinctive profile of genotypic abnormalities when compared to T‐ALL in older children and adults.

[1]  Cheng Cheng,et al.  The landscape of somatic mutations in Infant MLL rearranged acute lymphoblastic leukemias , 2015, Nature Genetics.

[2]  Rob Pieters,et al.  PTEN microdeletions in T-cell acute lymphoblastic leukemia are caused by illegitimate RAG-mediated recombination events. , 2014, Blood.

[3]  T. Druley,et al.  Excess congenital non-synonymous variation in leukemia-associated genes in MLL− infant leukemia: a Children's Oncology Group report , 2013, Leukemia.

[4]  C. Harrison,et al.  Genes commonly deleted in childhood B-cell precursor acute lymphoblastic leukemia: association with cytogenetics and clinical features , 2013, Haematologica.

[5]  R. Houlston,et al.  Developmental timing of mutations revealed by whole-genome sequencing of twins with acute lymphoblastic leukemia , 2013, Proceedings of the National Academy of Sciences.

[6]  R. Marschalek,et al.  The distribution of MLL breakpoints correlates with outcome in infant acute leukaemia , 2013, British journal of haematology.

[7]  真田 昌.  骨髄異形成症候群のgenome-wide analysis , 2013 .

[8]  M. Dyer,et al.  Biallelic ATM inactivation significantly reduces survival in patients treated on the United Kingdom Leukemia Research Fund Chronic Lymphocytic Leukemia 4 trial. , 2012, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

[9]  J. Downing,et al.  High-resolution genomic profiling of chronic lymphocytic leukemia reveals new recurrent genomic alterations. , 2012, Blood.

[10]  E. Schuuring,et al.  EuroClonality/BIOMED-2 guidelines for interpretation and reporting of Ig/TCR clonality testing in suspected lymphoproliferations , 2012, Leukemia.

[11]  A. Plessis,et al.  Myeloid leukemia factor is a conserved regulator of RUNX transcription factor activity involved in hematopoiesis , 2012, Proceedings of the National Academy of Sciences.

[12]  Kiran C. Bobba,et al.  The genetic basis of early T-cell precursor acute lymphoblastic leukaemia , 2012, Nature.

[13]  R. Hassan,et al.  Impact of complex NOTCH1 mutations on survival in paediatric T-cell leukaemia , 2012, BMC Cancer.

[14]  Kiran C. Bobba,et al.  Discovery of Novel Recurrent Mutations in Childhood Early T-Cell Precursor Acute Lymphoblastic Leukemia by Whole Genome Sequencing - a Report From the St Jude Children's Research Hospital - Washington University Pediatric Cancer Genome Project , 2011 .

[15]  A. Ferrando,et al.  Oncogenic IL7R gain-of-function mutations in childhood T-cell acute lymphoblastic leukemia , 2011, Nature Genetics.

[16]  D. Campana,et al.  Late recurrence of childhood T-cell acute lymphoblastic leukemia frequently represents a second leukemia rather than a relapse: first evidence for genetic predisposition. , 2011, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

[17]  D. Hanahan,et al.  Hallmarks of Cancer: The Next Generation , 2011, Cell.

[18]  S. Ogawa,et al.  Genomic profiling of adult acute lymphoblastic leukemia by single nucleotide polymorphism oligonucleotide microarray and comparison to pediatric acute lymphoblastic leukemia , 2010, Haematologica.

[19]  R. Marschalek,et al.  Identification of a MLL–MLLT4 fusion gene resulting from a t(6;11)(q27;q23) presenting as a del(11q) in a child with T-cell acute lymphoblastic leukemia , 2010, Leukemia & lymphoma.

[20]  R. Hassan,et al.  T-cell lymphoblastic leukemia in early childhood presents NOTCH1 mutations and MLL rearrangements. , 2010, Leukemia research.

[21]  L. Chin,et al.  High frequency of PTEN, PI3K, and AKT abnormalities in T-cell acute lymphoblastic leukemia. , 2009, Blood.

[22]  Cheng Cheng,et al.  Early T-cell precursor leukaemia: a subtype of very high-risk acute lymphoblastic leukaemia. , 2009, The Lancet. Oncology.

[23]  S. Koifman,et al.  SIL-TAL1 fusion gene negative impact in T-cell acute lymphoblastic leukemia outcome , 2009, Leukemia & lymphoma.

[24]  James R. Downing,et al.  Genomic Analysis of the Clonal Origins of Relapsed Acute Lymphoblastic Leukemia , 2008, Science.

[25]  P. Palange,et al.  From the authors , 2007, European Respiratory Journal.

[26]  Christopher B. Miller,et al.  Genome-wide analysis of genetic alterations in acute lymphoblastic leukaemia , 2007, Nature.

[27]  Charles Lee,et al.  The cryptic chromosomal deletion del(11)(p12p13) as a new activation mechanism of LMO2 in pediatric T-cell acute lymphoblastic leukemia. , 2006, Blood.

[28]  M. Pombo-de-Oliveira,et al.  Molecular cytogenetic findings of acute leukemia included in the Brazilian Collaborative Study Group of Infant acute leukemia , 2006, Pediatric blood & cancer.

[29]  J. Kato,et al.  Myeloid leukemia factor 1 regulates p53 by suppressing COP1 via COP9 signalosome subunit 3 , 2005, The EMBO journal.

[30]  Andrew P. Weng,et al.  Activating Mutations of NOTCH1 in Human T Cell Acute Lymphoblastic Leukemia , 2004, Science.

[31]  M Hummel,et al.  Design and standardization of PCR primers and protocols for detection of clonal immunoglobulin and T-cell receptor gene recombinations in suspect lymphoproliferations: Report of the BIOMED-2 Concerted Action BMH4-CT98-3936 , 2003, Leukemia.

[32]  C. Pui,et al.  Biological and therapeutic aspects of infant leukemia. , 2000, Blood.

[33]  M. Greaves,et al.  Backtracking leukemia to birth: identification of clonotypic gene fusion sequences in neonatal blood spots. , 1997, Proceedings of the National Academy of Sciences of the United States of America.

[34]  A Orfao,et al.  Proposals for the immunological classification of acute leukemias. European Group for the Immunological Characterization of Leukemias (EGIL). , 1995, Leukemia.

[35]  M. Greaves,et al.  In utero rearrangements in the trithorax-related oncogene in infant leukaemias , 1993, Nature.

[36]  Medical Faculty,et al.  High-Resolution Genomic Profiling of Chronic Lymphocytic Leukemia Reveals New Recurrent Genomic Alterations , 2014 .

[37]  R. Arceci.  The genetic basis of early T–cell precursor acute lymphoblastic leukaemia , 2012 .

[38]  M. Eguchi,et al.  NOTCH1 mutation can be an early, prenatal genetic event in T-ALL. , 2008, Blood.

[39]  T. Hoang,et al.  SCL: from the origin of hematopoiesis to stem cells and leukemia. , 2004, Experimental hematology.

[40]  Ken I. Mills,et al.  Design and standardization of PCR primers and protocols for detection of clonal immunoglobulin and T-cell receptor gene recombinations in suspect lymphoproliferations. Section 9. t(14;18) with BCL2-IGH rearrangement. , 2003 .

[41]  M. Greaves,et al.  Monoclonal origin of concordant T-cell malignancy in identical twins. , 1997, Blood.